chloramphenicol acetyl transferase
Recently Published Documents


TOTAL DOCUMENTS

59
(FIVE YEARS 1)

H-INDEX

17
(FIVE YEARS 0)

2021 ◽  
pp. 167276
Author(s):  
Olga Levin-Kravets ◽  
Alina Kordonsky ◽  
Anna Shusterman ◽  
Sagnik Biswas ◽  
Avinash Persaud ◽  
...  


2011 ◽  
Vol 32 (10) ◽  
pp. 783-789 ◽  
Author(s):  
Bieke Van Dorst ◽  
Jaytry Mehta ◽  
Elsa Rouah-Martin ◽  
Jelke Backeljau ◽  
Wim De Coen ◽  
...  


2005 ◽  
Vol 86 (7) ◽  
pp. 1891-1895 ◽  
Author(s):  
Mar Perez ◽  
Juan Carlos de la Torre

Borna disease virus (BDV) is an enveloped virus with a non-segmented, negative-strand RNA genome that has an organization characteristic of Mononegavirales. However, based on its unique genetics and biological features BDV is considered to be the prototypic member of a new virus family, Bornaviridae. Here, the use of a reverse genetic approach to identify the viral proteins required for packaging of BDV RNA analogues (MG) into infectious virus-like particles (VLPs) was described. Plasmids encoding individual BDV proteins under the control of a RNA polymerase II promoter were co-transfected with a plasmid that allows for intracellular synthesis of a BDV MG mediated by the cellular RNA polymerase I. Clarified lysates from transfected cells were passaged onto fresh cells that were previously transfected with plasmids expressing the minimal BDV trans-acting factors L, N and P required for RNA synthesis mediated by the BDV polymerase. Reconstitution of BDV MG-specific packaging and passage of infectious VLP was monitored by expression of the chloramphenicol acetyl transferase reporter gene present in the BDV MG. BDV M and G, in addition to L, N and P, were sufficient for the passage of chloramphenicol acetyl transferase activity, which could be blocked by BDV neutralizing antibodies to G, indicating that VLP infectivity was fully mediated by BDV G. Passage of BDV MG was abrogated by omission of either M or G.



2003 ◽  
pp. 793-803
Author(s):  
David R. Hodge ◽  
Delores M. Thompson ◽  
Alexandra Panayiotakis ◽  
Arun Seth




Author(s):  
Michael R. Davey ◽  
Nigel W. Blackhall ◽  
J. Brian Power




Endocrinology ◽  
2002 ◽  
Vol 143 (12) ◽  
pp. 4627-4635 ◽  
Author(s):  
Shao-Ling Zhang ◽  
Xing Chen ◽  
Chih-Chang Wei ◽  
Janos G. Filep ◽  
Shiow-Shih Tang ◽  
...  

Abstract The present studies investigated whether insulin inhibits the stimulatory effect of dexamethasone (DEX) on angiotensinogen (ANG) gene expression and induction of hypertrophy in rat immortalized renal proximal tubular cells (IRPTCs) in a high-glucose milieu. Rat IRPTCs were cultured in monolayer. ANG and ANG mRNA expression in IRPTCs were quantified by a specific RIA for rat ANG and by RT-PCR assay, respectively. A fusion gene containing the full length of the 5′-flanking region of the rat ANG gene linked to a chloramphenicol acetyl transferase reporter gene was introduced into IRPTCs. The level of fusion gene expression was determined by cellular chloramphenicol acetyl transferase enzymatic activity. Cellular hypertrophy was assessed by flow cytometry, cellular p27Kip1 protein expression, and protein assay. Our results showed that high glucose (i.e. 25 mm) and DEX (10−7m) additively stimulated ANG gene expression and induced IRPTC hypertrophy. Insulin inhibited the effect of high glucose and DEX on these parameters. The inhibitory effect of insulin was reversed by PD 98059 (a MAPK inhibitor) but not by wortmannin (a phosphatidylinositol-3-kinase inhibitor). These results demonstrate that insulin is effective in blocking the stimulatory action of high glucose and DEX on ANG gene expression and induction of IRPTC hypertrophy, suggesting its important role in preventing local intrarenal renin-angiotensin system activation and renal proximal tubular cell hypertrophy induced by hyperglycemia and glucocorticoids in vivo.



FEBS Letters ◽  
2002 ◽  
Vol 512 (1-3) ◽  
pp. 209-212 ◽  
Author(s):  
Vasanthi Ramachandiran ◽  
Gisela Kramer ◽  
Paul M Horowitz ◽  
Boyd Hardesty


Sign in / Sign up

Export Citation Format

Share Document